Breyer Capital

Warhound develops working dogs for military, law-enforcement and emergency-response teams.

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

Builds AI models trained on patient tissue and clinical data for disease diagnostics

Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology

Provides AI-powered medical search engine for clinicians

Uses cells as sensors to uncover first-in-class medicines